|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/535 | |||
| A61K 31/5575 | |||
| A61K 31/542 | |||
| A61K 45/06 | |||
| A61K 31/215 |
| (11) | Number of the document | 3042646 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15202422.0 |
| Date of filing the European patent application | 2009-03-13 | |
| (97) | Date of publication of the European application | 2016-07-13 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 37117 P | 2008-03-17 | US | |
| 111920 P | 2008-11-06 | US |
| (72) |
KABRA, Bhagwati, P., US
CARRERAS, Nuria, ES
GAL N, Francisco, Javier, ES
NARDA, Mridvika, ES
PUIG GONZ LEZ, Elena, ES
JIMÉNEZ, Nuria, ES
MART NEZ, Carmen, ES
CUCHI, M nica, ES
|
| (73) |
Alcon Research, Ltd.,
6201 South Freeway, Fort Worth, TX 76134-2099,
US
|
| (54) | PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY |
| PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY |